These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38997938)

  • 1. Testosterone and other treatments for transgender males and non-binary trans masculine individuals.
    Dimakopoulou A; Seal LJ
    Best Pract Res Clin Endocrinol Metab; 2024 Sep; 38(5):101908. PubMed ID: 38997938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and rapid efficacy of guideline-based gender-affirming hormone therapy: an analysis of 388 individuals diagnosed with gender dysphoria.
    Meyer G; Mayer M; Mondorf A; Flügel AK; Herrmann E; Bojunga J
    Eur J Endocrinol; 2020 Feb; 182(2):149-156. PubMed ID: 31751300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of gender affirming hormone treatment in transgender individuals - a retrospective cohort study.
    Muir CA; Guttman-Jones M; Man EJ
    Endocrine; 2024 Jul; 85(1):370-379. PubMed ID: 38386168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgender men: clinical care and implications in reproductive medicine: introduction.
    de Ziegler D; de Sutter P
    Fertil Steril; 2021 Oct; 116(4):919-921. PubMed ID: 34399947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent vaginal bleeding during gender-affirming hormone therapy in transgender men.
    da Silva ED; Spritzer PM; Fighera TM
    J Endocrinol Invest; 2024 Aug; 47(8):2053-2060. PubMed ID: 38300501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender-affirming hormone treatment: friend or foe? Long-term follow-up of 755 transgender people.
    Santi D; Spaggiari G; Marinelli L; Cacciani M; Scipio S; Bichiri A; Profeta A; Granata ARM; Simoni M; Lanfranco F; Manieri C; Ghigo E; Motta G
    J Endocrinol Invest; 2024 May; 47(5):1091-1100. PubMed ID: 37889433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of testosterone on ovulatory function in transmasculine individuals.
    Taub RL; Ellis SA; Neal-Perry G; Magaret AS; Prager SW; Micks EA
    Am J Obstet Gynecol; 2020 Aug; 223(2):229.e1-229.e8. PubMed ID: 32044312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender-affirming hormone treatment modalities for transfemale & non-binary transfeminine individuals: A UK perspective.
    Sagar RC; Millson-Brown V
    Best Pract Res Clin Endocrinol Metab; 2024 Sep; 38(5):101921. PubMed ID: 39232976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MANAGEMENT OF ENDOCRINE DISEASE: Optimal feminizing hormone treatment in transgender people.
    Glintborg D; T'Sjoen G; Ravn P; Andersen MS
    Eur J Endocrinol; 2021 Jun; 185(2):R49-R63. PubMed ID: 34081614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: A Long-Term Follow-Up Study on Prevalence, Determinants, and Exposure Years.
    Madsen MC; van Dijk D; Wiepjes CM; Conemans EB; Thijs A; den Heijer M
    J Clin Endocrinol Metab; 2021 May; 106(6):1710-1717. PubMed ID: 33599731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian, breast, and metabolic changes induced by androgen treatment in transgender men.
    Pirtea P; Ayoubi JM; Desmedt S; T'Sjoen G
    Fertil Steril; 2021 Oct; 116(4):936-942. PubMed ID: 34481638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine care of transpeople part I. A review of cross-sex hormonal treatments, outcomes and adverse effects in transmen.
    Meriggiola MC; Gava G
    Clin Endocrinol (Oxf); 2015 Nov; 83(5):597-606. PubMed ID: 25692791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contraception across the transmasculine spectrum.
    Krempasky C; Harris M; Abern L; Grimstad F
    Am J Obstet Gynecol; 2020 Feb; 222(2):134-143. PubMed ID: 31394072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrinology of Transgender Medicine.
    T'Sjoen G; Arcelus J; Gooren L; Klink DT; Tangpricha V
    Endocr Rev; 2019 Feb; 40(1):97-117. PubMed ID: 30307546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender-affirming hormone therapy for transgender and gender-diverse adults in Australia.
    Nolan BJ; Cheung AS
    Intern Med J; 2024 Sep; 54(9):1450-1457. PubMed ID: 39056542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombotic risk associated with gender-affirming hormone therapy.
    Mullins TLK; Mullins ES
    J Thromb Haemost; 2024 Aug; 22(8):2129-2139. PubMed ID: 38795871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-Term Effects of Gender-Affirming Hormone Therapy on Dysphoria and Quality of Life in Transgender Individuals: A Prospective Controlled Study.
    Foster Skewis L; Bretherton I; Leemaqz SY; Zajac JD; Cheung AS
    Front Endocrinol (Lausanne); 2021; 12():717766. PubMed ID: 34394009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low feasibility of in vitro matured oocytes originating from cumulus complexes found during ovarian tissue preparation at the moment of gender confirmation surgery and during testosterone treatment for fertility preservation in transgender men.
    Lierman S; Tolpe A; De Croo I; De Gheselle S; Defreyne J; Baetens M; Dheedene A; Colman R; Menten B; T'Sjoen G; De Sutter P; Tilleman K
    Fertil Steril; 2021 Oct; 116(4):1068-1076. PubMed ID: 33832736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications for management of ovarian cancer in a transgender man: Impact of androgens and androgen receptor status.
    Aubrey C; Saad N; Köbel M; Mattatall F; Nelson G; Glaze S
    Gynecol Oncol; 2021 May; 161(2):342-346. PubMed ID: 33663874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender-affirming hormone treatment and cognitive function in transgender young adults: a systematic review and meta-analysis.
    Karalexi MA; Georgakis MK; Dimitriou NG; Vichos T; Katsimpris A; Petridou ET; Papadopoulos FC
    Psychoneuroendocrinology; 2020 Sep; 119():104721. PubMed ID: 32512250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.